1. Lacy CF, Armstrong LL, Goldman MP. Drug Information Handbook. Hudson, OH: Lexi-Comp, 2000;1092–1100.

2. Hantson P, Leonard F, Maloteaux JM, Mahieu P. How epileptogenic are the recent antibiotics? Acta Clin Belg 1999;54:80–87.

3. Gilbert DN, Moellering RC, Sande MA. Guide to Antimicrobial Therapy. Hyde Park, VT: Antimicrobial Therapy, 2000;129–133.

4. Durack DT, Whitley RJ, Scheld WM. Approach to the patient with central nervous system infection. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;3.

5. Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38:1407–1410.

6. Iavanainen M, Hietala J, Malkamaki M, et al. An association between epileptic seizures and increased serum bacterial antibody levels. Epilepsia 1983;24:584–587.

7. Yuhas Y, Weizman A, Dinari G, et al. An animal model for the study of the neurotoxicity of bacterial products. J Infect Dis 1995;171:1244–1249.

8. Guess HA, Resseguie LJ, Melton LJ, et al. Factors predictive of seizures among intensive care unit patients with gram negative infections. Epilepsia 1990;31:567–573.

9. Jackson AC, Gilbert JJ, Young GB, et al. The encephalopathy of sepsis. Can J Neurol Sci 1985;12:303–307.

10. Roos KL, Tunkel AR, Scheld WM. Acute bacterial meningitis in children and adults. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;336–401.

11. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21–28.

12. Plum F, Posner JB. Infectious and Inflammatory Disorders of the Nervous System. In TE Andreoli, CC Carpenter, F Plum, et al. (eds), Cecil Essentials of Medicine. Philadelphia: Saunders, 1990;806–816.

13. Labar DR, Harden C. Infection and Inflammatory Diseases. In J Engel Jr, TA Pedley (eds), Epilepsy: a Comprehensive Textbook. Philadelphia: Lippincott–Raven, 1997;2587–2596.

14. Rosenberg NM, Meert K, Marino D, et al. Seizures associated with meningitis. Pediatr Emerg Care 1992;8:67–69.

15. Mylomakis E, Hohmann EL, Calderwood SB. Central nervous system dysfunction with Listeria monocyto- genes. Medicine 1992;77:313–336.

16. Kim JH, Durack DT. Rickettsiae. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;403–416.

17. Ries S, Schminke, Fassbender K, et al. Cerebrovascular involvement in the acute phase of bacterial meningitis. J Neurol 1997;244:51–55.

18. Chequer RS, Tharp BR, Dreimane D, et al. Prognostic value of EEG in neonatal meningitis. Pediatr Neurol 1992;8:417–422.

19. Inoue S, Nakazawa T, Takahashi H, et al. Seizures in the acute phase of aseptic and bacterial meningitis. No To Hattatsu 1998;30:494–499.

20. Grimwood K, Nolan TM, Bond L, et al. Risk factors for adverse outcomes of bacterial meningitis. J Paediatr Child Health 1996;32:457–462.

21. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993;12:389–394.

22. Cascino GD, Luckstein RR, Sharbrough FW, et al. Facial asymmetry, hippocampal pathology, and remote symptomatic seizures: a temporal lobe epileptic syndrome. Neurology 1993;43:725–727.

23. Rowland LP. Spirochete Infections: Neurosyphilis. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;200–212.

24. Hook EW. Syphilis. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;669–684.

25. Reik L. Lyme Disease. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;685–718.

26. Rahn DW, Felz MW. Lyme disease update. Postgraduate Medicine 1998;103:51–70.

27. Miller JR. Spirochete Infections: Lyme Disease. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;209–211.

28. Coyle PK, Deng Z, Schutzer SE, et al. Detection of Borrelia burgdorferi antigens in cerebrospinal fluid. Neurology 1993;43:1093–1097.

29. Lerner PI. Neurologic complications of infective endocarditis. Med Clin North Am 1985;69:385–398.

30. Pruitt AA, Rubin RH, Karchmer AW, et al. Neurologic complications of bacterial endocarditis. Medicine 1978;57:329–343.

31. Hantson P, Leonard F, Maloteaux JM, Mahieu P. How epileptogenic are the recent antibiotics? Acta Clin Belg 1999;54:80–87.

32. Calandra G, Lydick E, Carrigan J, et al. Factors predis- posing to seizures in seriously ill, infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med 1988;84:911–918.

33. Drug-induced convulsions. Report from Boston Collaborative Drug Surveillance Program. Lancet 1972;2:677–679.

34. Hodgman T, Dasta JF, Armstrong, et al. Ampicillin- associated seizures. South Med J 1984;77:1323–1325.

35. Grondahl TO, Langmoen IA. Epileptogenic effect of antibiotic drugs. J Neurosurg 1983;78:938–943.

36. Gerald MC, Massey J, Spadaro DC. Comparative convulsant activity of various penicillins after intracerebral injection in mice. J Pharm Pharmacol 1973;25:104–108.

37. Kamei C, Sunami A, Tasaka K. Epileptogenic activity of cephalosporins in rats and their structure-activity relationship. Epilepsia 1983;24:431–439.

38. Bechtel TP, Slaughter RL, Moore TD. Seizures associated with high cerebrospinal fluid concentrations of cefazolin. Am J Hosp Pharm 1980;37:271–273.

39. Yost RL, Lee JD, O’Leary JP. Convulsions associated with sodium cefazolin: a case report. Am Surg 1977;43:417–420.

40. Gardner ME, Fritz WL, Hyland RN. Antibiotic- induced seizure: a case attributed to cefazolin. Drug Intell Clin Pharm 1978;12:268–271.

41. Thompson JW, Jacobs RF. Adverse effects of newer cephalosporins: an update. Drug Saf 1993;9:132–142.

42. Jackson GD, Berkovic SF. Ceftazidime encephalopathy: absence status and toxic hallucinations. J Neurol Neurosurg Psychiatry 1992;55:333–334.

43. Hillsley RE, Massey EW. Truncal asterixes associated with ceftazidime, a third generation cephalosporin. Neurology 1991;41:2008.

44. Ceftazidime, penicillin, and the epilepsies [Editorial]. Lancet 1992;340:400–401.

45. Neu HC. Safety of cefepime: a new extended-spectrum parenteral cephalosporin. Am J Med 1996;100:68S–75S.

46. De Sarro A, Naccari F, Imperatore C, De Sarro GB. Comparative epileptogenic properties of two monobactam derivatives in C57, Swiss, and DBA/2 mice. J Antimicrob Chemother 1996;38:475–484.

47. Alvan G, Nord CE. Adverse effects of monobactams and carbapenems. Drug Saf 1995;12:305–313.

48. Ayroza Galvao PA, Milstein TM, Mimica IM, et al. Aztreonam in the treatment of bacterial meningitis. Chemotherapy 1989;35[Suppl 1]:39–44.

49. Brothrton TJ, Kelber RL. Seizure-like activity associated with imipenem. Clin Pharmacy 1984;3:536–540.

50. Tse ST, Vera FH, Desai DV. Seizure-like activity associated with imipenem-cilastatin. Drug Intell Clin Pharm 1987;21:629–660.

51. Eng RH, Munsif AN, Yongco BG, et al. Seizure propensity with imipenem. Arch Intern Med 1989;149:1881–1883.

52. Leo RJ, Ballow CH. Seizure activity associated with imipenem use: clinical case reports and review of the literature. Ann Pharmacother 1991;25:351–354.

53. De Sarro GB, Ammendola D, De Sarro A. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain Res 1995;671:131–140.

54. Norrby SR, Gildon KM. Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem. Scand J Infect Dis 1999;31:3–10.

55. Hellinger WC, Brewer NS. Carbapenems and monobactams: imipenem, meropenem, aztreonam. Mayo Clin Proc 1999;74:420–434.

56. Day IP, Goudie J, Nishiki K, Williams PD. Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics biapenem, imipenem/cilastatin, and meropenem. Toxicol Lett 1995;76:239–243.

57. Ball P. Adverse reactions and interactions of fluoroquinolones. Clin Invest Med 1989;12:28–34.

58. Halkin H. Adverse effects of fluoroquinolones. Rev Infect Dis 1988;10[Suppl 1]:S258–S261.

59. Anastasio GD, Menscer D, Little JM. Norfloxacin and seizures [Letter]. Ann Intern Med 1988;108:169–170.

60. Slavich IL, Gleffe RF, Haas EJ. Grand mal epileptic seizures during ciprofloxacin therapy. JAMA 1989;261:558–559.

61. Bader MB. Role of ciprofloxacin in fatal seizures. Chest 1992;101:883–884.

62. Akahan K, Sekiguchi M, Une T, Osada Y. Structure- epileptogenicity relationship of quinolones with special reference to their interaction with gamma- aminobutyric acid receptor sites. Antimicrob Agents Chemother 1989;33:1704–1708.

63. Vancutsem PM, Schwark WS. Effects of fluoroquinolone antimicrobials alone and in conjunction with theophylline on seizures in amygdaloid kindled rats: mechanistic and pharmacokinetic study. Epilepsy Res 1992:13:59–71.

64. Robson RA. The effects of quinolones on xanthine pharmacokinetics. Am J Med 1992;92:22S–25S.

65. Akahane K, Kimura Y, Tsutomi Y, et al. Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother 1994;38:2323–2329.

66. Akaike N, Shirasaki T, Yakushiji T. Quinolones and fenbufen interact with GABAA receptor in dissociated hippocampal cells of rat. J Neurophysiol 1991;66:497–504.

67. Segev S, Rehavi M, Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the GABA receptor. Antimicrob Agents Chemother 1988;32:1624–1626.

68. Wallace KL. Antibiotic-induced convulsions. Crit Care Clin 1997;13:741–762.

69. Schliamser SE, Cars O, Norrby SR. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother 1991;27:405–425.

70. Zuger A, Lowy FD. Tuberculosis. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;417–443.

71. Sumaya CV, Simek M, Smith MH, et al. Tuberculous meningitis in children during the isoniazid era. J Pediatr 1975;87:43–49.

72. Haas EJ, Madhava T, Quinn EL, et al. Tuberculous meningitis in an urban general hospital. Arch Intern Med 1977;137:1518–1521.

73. Clark WC, Metcalf JC, Muhlbauer MS, et al. Myco- bacterium tuberculous meningitis: report of 12 cases and literature review. Neurosurgery 1986;18:604–610.

74. Tseng MY, Kao MC, Chiu CT. Isolated leptomeningeal tuberculoma. J Formos Med Assoc 1999;98:361–364.

75. Tosomeen AH, Berbari EF, Levy NT, et al. Case report: a 26 year-old woman with seizures and multiple intracranial mass lesions. J Med Liban 1998;46:349–352.

76. Whitener DR. Tuberculous brain abscess: report of a case and review of the literature. J Neurosurg 1982;56:597–600.

77. Lesprit P, Zagdanski AM, de La Blanchardiere A, et al. Cerebral tuberculosis in patients with the acquired immunodeficiency syndrome (AIDS). Report of six cases and review. Medicine 1997;76:423–431.

78. Martinez-Vazquez C, Bordon J, Rodriguez-Gonzalez A, et al. Cerebral tuberculoma—a comparative study in patients with and without HIV infection. Infection 1995;23:149–153.

79. Brennan RW, Deheija H, Kutt H, et al. Diphenylhydantoin intoxication attendant to slow acetylation of isoniazid. Neurology 1970;21:383–385.

80. Valsdon VC, Cooper GL. Carbamazepine intoxication caused by interaction with isoniazid. BMJ 1982;285:261–262.

81. Sullivan EA, Geoffroy P, Weisman R, et al. Isoniazid poisonings in New York City. J Emerg Med 1998;16:57–59.

82. Clyde WA. Mycoplasmal Diseases. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;603–612.

83. Caceres ME, de los Reyes EC, Khan R, et al. Acute encephalopathy and intractable seizures in a 10 year- old boy. Semin Pediatr Neurol 1999;6:229–231.

84. Aminoff MJ, Greenberg DA, Simon RP. Clinical Neurology. Stamford, CT: Appleton & Lange, 1996;29–30.

85. Cassady KA, Whitley RJ. Pathogenesis and Patho- physiology of Viral Infections of the Central Nervous System. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;7–22.

86. Summary of notifiable diseases, United States. 1990. MMWR Morb Mortal Wkly Rep 1991;39:1–61.

87. Weber T, Frye S, Bodemer M, et al. Clinical implications of nucleic acid amplification methods for diagnosis of viral infections of the nervous system. J Neurovirol 1996;2:175–190.

88. Whitley RJ. Herpes Simplex Virus. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;73–89.

89. Whitley R. Viral encephalitis. N Engl J Med 1990;323:242–250.

90. Whitley R, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 1995;20:414–420.

91. Barnett E, Jacobsen G, Evans G, et al. Herpes simplex encephalitis in the temporal cortex and limbic system after trigeminal nerve inoculation. J Infect Dis 1994;169:782–786.

92. Twomey J, Barker C, Robinson G, et al. Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 1979;42:983–987.

93. Stroop WG, Schaefer DC. Neurovirulence of two clonally related HSV-1 strains in a rabbit seizure model. J Neuropathol Exp Neurol 1989;48:171–183.

94. Jay V, Becker LE, Blaser S, et al. Pathology of chronic herpes infection associated with seizure disorder: a report of HSV-1 detection by PCR. Pediatr Pathol Lab Med 1995;15:131–146.

95. Jay V, Hwang P, Hoffman HJ, et al. Intractable seizure disorder associated with chronic herpes infection. Childs Nerv Syst 1998;14:15–20.

96. Jubelt B, Miller JR. Viral Infections. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;142–179.

97. Schlitt M, Bucher AP, Stroop WG, et al. Neurovirulence in an experimental focal encephalitis: relationship to observed seizures. Brain Res 1988;440:293–298.

98. Cornford ME, McCormick GF. Adult-onset temporal lobe epilepsy associated with smoldering herpes simplex 2 infection. Neurology 1997;48:425–430.

99. Ross JP, Cohen JI. Epstein-Barr Virus. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;117–127.

100. Domachowske JB, Cunningham CK, Cummings DL, et al. Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children. Pediatr Infect Dis J 1997;16:336–337.

101. Kimberlin DW, Whitley RJ. Human herpesvirus 6: neurologic implications of a newly-described viral pathogen. J Neurovirol 1998;4:471–473.

102. Suga S, Yoshikawa T, Asano Y, et al. Clinical and viro- logical analyses of 21 infants with exanthem subitum (roseola infantum) and CNS complications. Ann Neurol 1993;33:597–603.

103. Hall S, Long CE, Schnabel KC, et al. Human herpesvirus 6 infection in children: a prospective study of complications and reactivation. N Engl J Med 1994;331:432–438.

104. Barone SR, Kaplan MH, Krilov LR. Human herpesvirus 6 infection with first febrile seizures. J Pediatr 1995;127:95–97.

105. Hukin J, Farrell K, MacWilliam LM, et al. Case-control study of primary human herpesvirus 6 infection in children with febrile seizures. Pediatrics 1998;101:E3.

106. Hosoya M, Honzumi K, Suzuki H. Detection of enterovirus by PCR and culture in CSF of children with transient neurologic complications associated with acute febrile illness. J Infect Dis 1997;175:700–703.

107. Griffiths PD, McLaughlin JE. Cytomegalovirus. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;107–115.

108. Whitley RJ. Arthopod-Borne Encephalitides. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;147–168.

109. Tsai T. Arboviral infections in the United States. Infect Dis Clin North Am 1991;5:73–102.

110. Bale J. Viral encephalitis. Med Clin North Am 1993;77:25–42.

111. City Health Information 2000 (pamphlet). New York: New York City Department of Health, 2000;19(1):1–5.

112. Outbreak of West Nile-like viral encephalitis—NewYork, 1999. MMWR Morb Mortal Wkly Rep 1999;48:845–849.

113. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999;286:2333–2337.

114. Berger JR, Simpson DM. Neurologic Complications of AIDS. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;255–271.

115. Britton CB. Acquired immunodeficiency syndrome. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;179–193.

116. Holtzman D, Kaku D, So Y. New-onset seizures associated with HIV infection: causation and clinical features in 100 cases. Am J Med 1989;87:173–177.

117. Aronow H, Feraru E, Lipton R. New-onset seizures in AIDS patients: etiology, prognosis, and treatment. Neurology 1989;39[Suppl 1]:428.

118. van Paesschen W, Bodian C, Maker H. Metabolic abnormalities and new-onset seizures in HIV-seropositive patients. Epilepsia 1995;36:146–150.

119. Pesola GR, Westfal RE. New-onset generalized seizures in patients with AIDS presenting to an emergency department. Acad Emerg Med 1998;5:905–911.

120. Rothman RE, Keyl PM, McArthur JC, et al. A decision guideline for emergency department utilization of non- contrast head CT in HIV-infected patients. Acad Emerg Med 1999;6:1010–1019.

121. Pascual-Sedano B, Iranzo A, Marti-Fabregas J, et al. Prospective study of new-onset seizures in patients with HIV infection: etiologic and clinical aspects. Arch Neurol 1999;56:609–612.

122. Bartolomei F, Gavaret M, Dhiver C, et al. Isolated, chronic, epilepsia partialis continua in an HIV-infected patient. Arch Neurol 1999;56:111–114.

123. Ferrari S, Monaco S, Morbin M, et al. HIV-associated PML presenting as epilepsia partialis continua. J Neurol Sci 1998;161:180–184.

124. Harden C, Daras M, Tuchman A et al. Low amplitude EEGs in demented AIDS patients. Electroencephalogr Clin Neurophysiol 1993;87:544–546.

125. Gabuzda D, Levy S, Chiappa K. EEG in AIDS and AIDS-related complex. Clin Electroencephalogr 1988;19:1–6.

126. Jennings HR, Romanelli F. The use of valproic acid in HIV-positive patients. Ann Pharmacother 1999;33:1113–1116.

127. Wong M, Suite N, Labar D. Seizures in HIV infection. Arch Neurol 1990;47:640–642.

128. Koppel B, Harden C, McCoy B, et al. Antiepileptic drug treatment in patients with AIDS. Epilepsia 1992;33:69.

129. Jubelt B, Ropka S. Infectious Diseases of the Nervous System. In R Rosenberg (ed), Atlas of Clinical Neurology. Boston: Butterworth–Heinemann, 1998;44–46.

130. Asher DM. Slow Viral Infections. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;199–221.

131. Johnson RT, Gibbs CJ. Medical progress: Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994–2004.

132. Brandel J-P, Delasnerie-Laupretre N, Laplanche J-L, et al. Diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;54:1095–1099.

133. Zerr I, Bodemer M, Geller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32–40.

134. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999;56:577–583.

135. Brown P, Cathala F, Sadowsky D, et al. Creutzfeldt-Jacob disease in France: clinical characteristics of 124 consecutive verified cases. Ann Neurol 1979;6:430–437.

136. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513–529.

137. Aminoff MJ, Greenberg DA, Simon RP. Clinical Neurology. Stamford, CT: Appleton & Lange, 1996;58–59.

138. Perfect JR, Durack DT. Fungal Meningitis. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;721–739.

139. Posner JP. Neurologic Complications of Cancer. Philadelphia: FA Davis Co, 1995;230–263.

140. Prockop LD. Fungal and Yeast Infections. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;193–198.

141. Sepkowitz K, Armstrong D. Space-Occupying Fungal Lesions. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;741–762.

142. Sutton DA, Slifkin M, Yakulis R, et al. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neuro- tropic taxa. J Clin Microbiol 1998;36:708–715.

143. Bhagatm K, Ibrahim H, Naik K. Not everything acid- fast is Mycobacterium tuberculosis—a case of Nocardia. Cent Afr J Med 1999;45:217–220.

144. Cegielski JP, Warrell DA. Cerebral Malaria. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;765–784.

145. Warrell D, Molyneux ME, Beales PF. Severe and complicated malaria (2nd ed). (World Health Organization Malaria Action Program). Trans R Soc Trop Med Hyg 1990;84[Suppl 2]:1–65.

146. Molyneux ME, Taylor TE, Wirima JJ, et al. Clinical features and prognostic indicators in pediatric cerebral malariae: a study of 131 Malawian children. Q J Med 1989;71:441–459.

147. Marsden PD, Bruce-Chwatt LJ. Cerebral malaria. Contemp Neurol Ser 1975;12:29–44.

148. Dukes CS, Luft BJ, Durack DT. Toxoplasmosis. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;785–806.

149. McCabe RE, Brooks RG, Dorfman RF, et al. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 1987;9:754–774.

150. Jubelt B, Miller JR. Parasitic Infections. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;212–222.

151. Porter S, Sande M. Toxoplasmosis of the central nervous system in AIDS. N Engl J Med 1992;327:1643–1648.

152. Ragnaud J, Morlat P, Dupon M, et al. Cerebral toxoplasmosis in AIDS. Presse Med 1993;22:903–908.

153. Ketonen LM, Berg MJ. Clinical Neuroradiology. New York: Oxford University Press, 1997;118–120.

154. Georgiev V. Management of toxoplasmosis. Drugs 1994;48:79–88.

155. Cegielski JP, Durack DT. Trypanosomiasis. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;807–829.

156. Wery M. Drugs used in treatment of sleeping sickness. Int J Antimicrob Agents 1994;4:227–238.

157. Pepin J, Milord F, Khonde AN, et al. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei sleeping sickness. Trans R Soc Trop Med Hyg 1995;89:92–97.

158. Hamon JF, Camara P. Electroencephalographic study of meningoencephalitis from Trypanosoma gambiense before and after treatment with melarsoprol. Neurophysiol Clin 1991;21:173–181.

159. Rocha A, de Meneses AC, da Silva AM, et al. Pathology of patients with Chagas’ disease and AIDS. Am J Trop Med Hyg 1994;50:261–268.

160. Aminoff MJ, Greenberg DA, Simon RP. Clinical Neurology. Stamford, CT: Appleton & Lange, 1996;37.

161. Durack DT. Amebic infections. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;831–844.

162. Cameron ML, Durack DT. Helminthic Infections. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;845–878.

163. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Medical Research Council Special Report Series 1961;299:1–58.

164. del Brutto O, Santibanez R, Noboa C, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;44:1706–1709.

165. Medina M, Rosas E, Rubio-Donnadieu F, et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150:325–327.

166. Wei GZ, Li CJ, Meng JM, Ding MC. Cysticercosis of the central nervous system. A clinical study of 1,400 cases. Chin Med J 1988;101:493–500.

167. del Brutto OH, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis 1988;10:1075–1087.

168. Estnol B, Carona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol 1986;49:1131–1134.

169. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696–701.

170. Botero D, Uribe C, Sanchez J, et al. Short course albendazole treatment for neurocysticercosis. Trans R Soc Trop Med Hyg 1993;87:576–577.

171. Takayanagui O, Jardim E. Therapy for neurocysticercosis. Arch Neurol 1992;49:290–294.

172. Rueda-Franco F. Surgical considerations of neurocysticercosis. Childs Nerv Syst 1987;3:212.

173. Schantz PM, Okelo GB. Echinococcosis. In KS Warren, AA Mahmoud (eds), Tropical and Geographic Medicine. New York: McGraw-Hill, 1990;505–518.

174. Mawhorter S, Kazura J. Trichinosis of the central nervous system. Semin Neurol 1993;13:148–152.

175. Arpino C, Gattinara GC, Piergili D, et al. Toxocara infection and epilepsy in children: a case-control study. Epilepsia 1990;31:33–36.

176. Mikhael NZ, Montpetit VJ, Orizaga M, et al. Toxocara canis infestation with encephalitis. Can J Neurol Sci 1974;1:114–120.

177. Glickman L, Cypress R, Crumrine I, et al. Toxocara infection and epilepsy in children. J Pediatr 1979; 94:75–78.

178. Scrimgeour EM, Gajdusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. hematobium infection. Brain 1985;108:1023–1038.

179. Liu L. Spinal and cerebral schistosomiasis. Semin Neurol 1993;13:189–200.

180. Miller JR, Jubelt B. Bacterial Infections. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;119.

181. Berg L, Klebanoff LM. Focal infections. In LP Rowland (ed), Merritt’s Textbook of Neurology. Baltimore: Williams & Wilkins, 1995;136–142.

182. Pathak A, Sharma BS, Mathuriya SN, et al. Controversies in the management of subdural empyema. Acta Neurochir (Wien) 1990;102:25–32.

183. Aminoff MJ, Greenberg DA, Simon RP. Clinical Neurology. Stamford, CT: Appleton & Lange, 1996;297–298.

184. Britt RH, Enzmann DR, Yaeger AS. Neuropathological and CT findings in experimental brain abscess. J Neurosurg 1981;55:590–603.

185. Mampalam TJ, Rosenblum ML. Trends in the management of bacterial brain abscesses. Neurosurgery 1988;23:451–458.

186. Whelan MA, Hilal SK. CT as a guide in diagnosis and follow-up of brain abscesses. Radiology 1980;135:663–671.

187. Fenichel GM. Clinical Pediatric Neurology. Philadelphia: Saunders, 1997;18–19.

188. Green SM, Rothrock SG, Clem KJ, et al. Can seizures be the sole manifestation of meningitis in febrile children? Pediatrics 1993;92:527–543.

189. Teach SJ, Geil PA. Incidence of bacteremia, urinary tract infections, and unsuspected bacterial meningitis in children with febrile seizures. Pediatr Emerg Care 1999;15:9–12.

190. Al-Eissa YA. Lumbar puncture in the clinical evaluation of children with seizures associated with fever. Pediatr Emerg Care 1995;11:347–350.

191. Rantala H, Uhari M, Tuokko H. Viral infections and recurrences of febrile convulsions. J Pediatr 1990;117:510–511.

192. Pruitt AA. Central nervous system infections in cancer patients. Neurol Clin 1991;9:867–888.

193. Griffen DE. Measles. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;47–56.

194. Patel SP, Friedman RS. Neuropsychiatric features of acute disseminated encephalomyelitis. J Neuropsychiatry Clin Neurosci 1997;9:534–540.

195. Hirtz DG, Nelson KB, Ellenberg JH. Seizures following childhood immunizations. J Pediatr 1983;102:14–18.

196. Kesselring J, Miller DH, Robb SA. Acute disseminated encephalomyelitis—MRI findings and the distinction from multiple sclerosis. Brain 1990;113:291–302.

197. Kepes JJ. Large tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? Ann Neurol 1993;33:137–141.

198. Kimberlin DW, Plotkin SA. Vaccines for Viral Diseases with Significant CNS Manifestations. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;983–1012.

199. Gripshover BM, Ellner JJ. Chronic Meningitis Syndrome and Meningitis of Noninfective or Uncertain Etiology. In WM Scheld, RJ Whitley, DT Durack (eds), Infections of the Central Nervous System. Philadelphia: Lippincott–Raven, 1997;881–896.

200. Schmidley JW, Simon RP. Postictal pleocytosis. Ann Neurol 1981;9:81–84.

201. Centers for Disease Control and Prevention. West Nile Virus: Statistics, Surveillance, and Control. Available athttp://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03_detailed.htm. Accessed March 12, 2004.

202. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258.

203. American College of Emergency Physicians: Clinical policy for the initial approach to patients presenting with a chief complaint of seizure who are not in status epilepticus. Ann Emerg Med May 1997;29:706-724. Available athttp://www.acep.org/library/pdf/archives/Cp402070.pdf, accessed March 24, 2004.